ORLANDO - Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products with a market capitalization of $74 million, announced Monday that it has received a Notice of ...

Report with market evolution powered by AI - The global nicotine patch market size is estimated to grow by USD 494.1 million ...

The U.S. Food and Drug Administration announced last week that a pharmaceutical company is removing a fentanyl patch from ...

Alvogen has issued a nationwide recall of one lot of Fentanyl Transdermal System 25 patches because the patches may stick ...

Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches ...

Doctors weigh in on the new entrant into the self-care domain, the wellness patch, that has found its spot in Katrina Kaif ...

On the basis of clinical observation of single cases treated by transdermal nicotine, it appears that clinical response may vary to a major extent between individuals. This variability may be ...

The first transdermal patch, Scopolamine, for motion sickness, was approved in 1979 by the U.S. Food and Drug Administration (FDA). The arrival of nicotine patches in 1992 led to transdermal ...

Introduction: Traditional Miao and Dai Chinese medicines have used nicotine-rich leaf tobacco to treat traumatic injuries by promoting hemostasis. While nicotine is known to enhance platelet ...

Additionally, the existing research has mixed results. As such, researchers are investigating the potential of nicotine patches and whether they could help delay or prevent Alzheimer’s disease.

Zyn nicotine pouches loved by young people for their appetite-suppressing effects have officially been approved in the US. The FDA said it found the pouches were a safer alternative to cigarettes ...

The Food and Drug Administration (FDA) announced on Thursday that it authorized the marketing of Zyn nicotine pouches but will be "closely monitoring youth use." "The FDA's decision recognizes the ...